Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Rikhia Chakraborty, Oliver A. Hampton, Xiaoyun Shen, Stephen J. Simko, Albert Shih, Harshal Abhyankar, Karen Phaik Har Lim, Kyle R. Covington, Lisa Trevino, Ninad Dewal, Donna M. Muzny, Harshavardhan Doddapaneni, Jianhong Hu, Linghua Wang, Philip J. Lupo, M. John Hicks, Diana L. Bonilla, Karen C. Dwyer, Marie Luise Berres, Poulikos I. PoulikakosMiriam Merad, Kenneth L. McClain, David A. Wheeler, Carl E. Allen, D. Williams Parsons

Research output: Contribution to journalArticlepeer-review

228 Scopus citations

Fingerprint

Dive into the research topics of 'Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds